ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF - USD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.951 USD | +1.04% |
|
+0.70% | -6.72% |
Investment objective
The iShares Nasdaq US Biotechnology UCITS ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ.
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 399 USD | +0.32% | +1.22% | -1.92% | 8.46% | ||
| 883.9 USD | -0.76% | -1.51% | +0.57% | 7.85% | ||
| 270.4 USD | +0.38% | +0.47% | -6.19% | 7.84% | ||
| 65.64 USD | +0.57% | -1.72% | -19.01% | 7.77% | ||
| 209.3 USD | +3.40% | +7.64% | -19.14% | 3.86% | ||
| 107.8 USD | +1.54% | +6.38% | +8.48% | 3.85% | ||
| 144.8 USD | +0.79% | +0.58% | -24.12% | 2.51% | ||
| 123.4 USD | +1.90% | +4.88% | -11.55% | 2.31% | ||
| 81.64 USD | -0.65% | -7.95% | -15.39% | 1.87% | ||
More news
In partnership with
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 5.951 | +1.04% | 52 661 |
| 24-04-25 | 5.89 | -2.02% | 76,572 |
| 24-04-24 | 6.011 | -0.72% | 26,803 |
| 24-04-23 | 6.055 | +2.67% | 23,289 |
| 24-04-22 | 5.898 | +0.60% | 124,988 |
Other stock markets
Delayed Quote London S.E.
Last update April 26, 2024 at 11:35 am EDT
More quotesDescription
| IE00BYXG2H39 | |
|---|---|
| Total Expense Ratio | 0.35% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | NASDAQ Biotechnology Net Total Return Index - USD |
Features and characteristics
| Jurisdiction | |
| Replication Method | |
| Replication Model | |
| Date of creation |
2017-10-18
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 2024-03-27 )
| AuM (EUR) | 443 M€ |
|---|---|
| AuM 1M | 426 M€ |
| AuM 3 months | 406 M€ |
| AuM 6 months | 364 M€ |
| AuM 12 months | 426 M€ |
- Stock Market
- ETF
- BTEK ETF
